CJC-1295 & Ipamorelin

Storage and Reconstitution for Both Compounds

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Both are supplied lyophilised and most stable dry, cold and dark, and neither contains cysteine or methionine. The DAC form differs in one important way: its maleimide group is deliberately reactive toward thiols, which is a handling consideration the others do not have.

Key facts

Both supplied as
Lyophilised powder
Cysteine / methionine
Neither, in either compound
Ipamorelin MW
711.9 Da
CJC-1295 MW
3647.2 (DAC) / 3367.9 (non-DAC)
DAC-specific concern
Maleimide reacts with free thiols
Avoid with DAC form
Thiol-containing buffers

What the two share

Both lack cysteine and methionine, so disulfide chemistry and thioether oxidation do not apply to either. Both are supplied lyophilised, and both are most stable dry, cold and protected from light. Both should be reconstituted gently against the vial wall and swirled rather than shaken, since foaming indicates the air-liquid interface at which peptides denature.

The DAC form's specific reactivity

This is the one truly distinctive handling point in the category. The maleimide group exists to react with a free thiol; that is its entire purpose. It will react with any accessible thiol, not only albumin's Cys34. A buffer containing dithiothreitol, β-mercaptoethanol or free cysteine will consume the linker and destroy the conjugation chemistry before it reaches its intended target.

Research material referenced

CJC-1295 + Ipamorelin 5+5mg, third-party HPLC tested

Buy CJC-1295 + Ipamorelin · £42.99

Why that matters more than usual

For most peptides, a reducing agent in buffer is unnecessary but harmless. For the DAC form it is actively destructive, and the damage is invisible: the peptide remains intact and simply loses its ability to bind albumin. Nothing about the material would look wrong, and the half-life advantage would silently disappear.

Different masses, one common error

Ipamorelin at 711.9 Da and CJC-1295 at 3647.2 differ more than fivefold. Because the two are so routinely prepared together, using one molecular weight for the other is an easy and consequential slip. Labelling aliquots with the compound and its mass is a small discipline that prevents it.

After reconstitution

Aliquot into single-use volumes to avoid repeated freeze-thaw cycling, which concentrates solutes at the ice boundary and creates fresh interfaces each cycle. Ipamorelin's aromatic residues give it a useful 280 nm absorbance for concentration checking; CJC-1295 has aromatics too, from the tyrosines and phenylalanine in the GHRH sequence.

Frequently asked questions

Should I add a reducing agent?

No, and for the DAC form specifically it is destructive. The maleimide will react with the reducing agent's thiol instead of albumin's, silently removing the half-life advantage.

Do both compounds need the same handling?

Largely, but the DAC form's maleimide reactivity is unique to it. Neither contains cysteine or methionine.

What is the most common preparation error here?

Using one compound's molecular weight for the other. They differ more than fivefold and are usually prepared together.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More CJC-1295 & Ipamorelin articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.